NasdaqCM - Delayed Quote USD
Clearmind Medicine Inc. (CMND)
At close: November 22 at 4:00 PM EST
After hours: November 22 at 6:41 PM EST
Breakdown
TTM
10/31/2023
10/31/2022
10/31/2021
10/31/2020
Operating Expense
4,124.7523
4,557.9623
4,593.4993
2,173.3388
175.0585
Operating Income
-4,124.7523
-4,557.9623
-4,593.4993
-2,173.3388
-175.0585
Net Non Operating Interest Income Expense
181.0552
42.7882
-10.5935
--
--
Other Income Expense
-1,821.4681
-1,705.9221
-440.2585
-25.7333
-134.8773
Pretax Income
-5,765.1652
-6,221.0962
-5,044.3513
-2,199.0720
-309.9359
Tax Provision
287.3886
12.5616
21.9401
--
--
Net Income Common Stockholders
-6,052.5538
-6,233.6578
-5,066.2914
-2,199.0720
-309.9359
Diluted NI Available to Com Stockholders
-6,052.5538
-6,233.6578
-5,066.2914
-2,199.0720
-309.9359
Basic EPS
-1.23
-30.79
-159.60
-71.14
-17.11
Diluted EPS
-1.23
-30.79
-159.60
-71.14
-17.11
Basic Average Shares
2,172.8960
202.4800
43.3340
30.9100
18.1300
Diluted Average Shares
2,172.8960
202.4800
43.3340
30.9100
18.1300
Rent Expense Supplemental
--
--
--
--
9.0824
Total Expenses
4,124.7523
4,557.9623
4,593.4993
2,173.3388
175.0585
Net Income from Continuing & Discontinued Operation
-6,052.5538
-6,233.6578
-5,066.2914
-2,199.0720
-309.9359
Normalized Income
-4,518.3292
-5,210.1045
-4,741.4247
-2,173.3388
-175.0585
Interest Expense
--
--
14.4592
--
--
Net Interest Income
181.0552
42.7882
-10.5935
--
--
EBIT
-4,124.7523
-4,557.9623
-4,593.4993
-2,173.3388
-309.9359
EBITDA
-4,097.1003
-4,516.3773
-4,532.4624
-2,171.8169
-309.9359
Reconciled Depreciation
27.6520
41.5850
61.0369
1.5202
--
Net Income from Continuing Operation Net Minority Interest
-6,052.5538
-6,233.6578
-5,066.2914
-2,199.0720
-309.9359
Total Unusual Items Excluding Goodwill
-1,804.9701
-1,705.9221
-440.2585
-25.7333
-134.8773
Total Unusual Items
-1,804.9701
-1,705.9221
-440.2585
-25.7333
-134.8773
Normalized EBITDA
-2,292.1302
-2,810.4552
-4,092.2039
-2,146.0836
-175.0585
Tax Rate for Calcs
0.0002
0.0004
0.0003
--
--
Tax Effect of Unusual Items
-270.7455
-682.3688
-115.3918
--
--
10/31/2020 - 11/15/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SPRC SciSparc Ltd.
0.2453
-14.29%
PXMD PaxMedica, Inc.
0.0995
+42.14%
DRMA Dermata Therapeutics, Inc.
1.1371
-3.64%
REVB Revelation Biosciences, Inc.
0.7550
+0.27%
SLRX Salarius Pharmaceuticals, Inc.
1.3700
-6.16%
CGTX Cognition Therapeutics, Inc.
0.4277
-2.75%
PALI Palisade Bio, Inc.
2.4400
0.00%
CDIO Cardio Diagnostics Holdings, Inc.
0.2654
+7.28%
QNRX Quoin Pharmaceuticals, Ltd.
0.5850
-6.43%
ZVSA ZyVersa Therapeutics, Inc.
1.1300
-0.88%